Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Dapagliflozin 5Mg Tab;   Drug: Glimepiride 4Mg Tab Sponsors:   Damanhour University;   Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2020 Category: Research Source Type: clinical trials

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
Condition:   Diabetic Patients Interventions:   Dietary Supplement: Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral;   Drug: Glimepiride Sponsor:   Damanhour University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2019 Category: Research Source Type: clinical trials

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Rosuvastatin10 mg tablet;   Drug: Placebo Oral Tablet Sponsor:   Damanhour University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2019 Category: Research Source Type: clinical trials

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Placebo, Nicorandil, Glimepiride Sponsor:   University of Copenhagen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Placebo, Nicorandil, Glimepiride Sponsor:   University of Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2018 Category: Research Source Type: clinical trials

Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2 Interventions:   Drug: Vildagliptin 50 mg Oral Tablet;   Drug: Metformin 1000 mg Oral Tablet;   Drug: Glimepiride 4 mg Oral Tablet Sponsor:   Damanhour University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2018 Category: Research Source Type: clinical trials